Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
1 other identifier
interventional
38
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the effects of dual-task training on upper extremity function and muscle thickness in individuals with Parkinson's disease. The main questions it aims to answer are: Does dual-task training improve upper extremity function in individuals with Parkinson's disease? Does dual-task training lead to changes in upper extremity muscle thickness measured by ultrasonography? Researchers will compare a dual-task training group with a control group receiving routine care to determine whether 8 weeks of dual-task training results in greater improvements in upper extremity outco Participants will: complete baseline and post-intervention assessments of upper extremity function, muscle thickness, grip strength, and pinch strength be assigned to either a control group or a dual-task training group receive dual-task training 3 days per week for 8 weeks if assigned to the intervention group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedStudy Start
First participant enrolled
April 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 24, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 17, 2026
April 1, 2026
3 months
April 11, 2026
April 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Upper Extremity Function
Upper extremity function will be assessed using the Purdue Pegboard Test. Performance will be recorded as the number of pins placed within the specified time for dominant hand, nondominant hand, and both hands; higher scores indicate better fine motor performance and manual dexterity.
Baseline and 8 weeks
Upper Extremity Muscle Thickness
Muscle thickness of the deltoid, biceps brachii, triceps brachii, and forearm flexor muscles will be measured using ultrasonography. The mean of three repeated measurements for each site will be recorded in millimeters.
Baseline and 8 weeks
Hand Grip Strength
Hand grip strength will be measured using a Jamar hydraulic hand dynamometer according to the ASHT protocol. The mean of three trials will be recorded.
Baseline and 8 weeks
Pinch Strength
Lateral pinch, three-jaw chuck pinch, and two-point pinch strength will be assessed using a pinch meter. The mean of three trials will be recorded in kilograms or Newtons.
Baseline and 8 weeks
Study Arms (2)
Dual-Task Training Group
EXPERIMENTALParticipants will receive dual-task training in addition to their routine daily activities. The training program will be performed 3 times per week for 8 weeks, with each session lasting 60 minutes and consisting of combined motor and cognitive tasks.
Control Group
NO INTERVENTIONParticipants will continue their routine daily activities without receiving any additional exercise, training, or rehabilitation intervention during the study period.
Interventions
Dual-task training will be applied 3 times per week for 8 weeks, with each session lasting 60 minutes. The program combines motor tasks (such as peg placement, object manipulation, bilateral coordination, and mobility tasks) with simultaneous cognitive tasks (such as backward counting, category-based word generation, and memory tasks).
Eligibility Criteria
You may qualify if:
- Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
- Modified Hoehn and Yahr stage 2 to 3
- No medication or dosage change within the last 6 months
- Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score ≥21
- Voluntary participation with written informed consent
You may not qualify if:
- Atypical or secondary parkinsonism
- Advanced orthopedic condition affecting the upper extremity
- Surgery, trauma, or immobilization involving the upper extremity within the last 6 months
- Wound or dermatological condition preventing upper extremity ultrasonographic evaluation
- Severe visual or hearing loss
- Severe depression, psychosis, or communication difficulty
- Any additional health problem preventing regular participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ankara Universitylead
- Hacettepe Universitycollaborator
Study Sites (1)
Hacettepe University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Büşra Seçkinoğulları Korkusuz
Ankara University
- STUDY CHAIR
Süleyman Korkusuz
Atılım University
- STUDY CHAIR
Ayşenur Özcan
Çankırı Karatekin University
- STUDY CHAIR
Ayla Fil
Hacettepe University
- STUDY CHAIR
Gül Yalçın Çakmaklı
Hacettepe University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof. Dr
Study Record Dates
First Submitted
April 11, 2026
First Posted
April 17, 2026
Study Start
April 24, 2026
Primary Completion (Estimated)
July 24, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share